Skip to main content

Celgene shares pop after top proxy advisor ISS recommends Bristol-Myers investors approve buyout bid

Institutional Shareholder Services recommends Bristol-Myers Squibb shareholders vote in favor of its bid to buy Celgene.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.